Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System

Rui Tao and Sidney B. Auerbach
Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 549-556; DOI: https://doi.org/10.1124/jpet.102.037861
Rui Tao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sidney B. Auerbach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Opioid receptor subtypes may have site-specific effects and play different roles in modulating serotonergic neurotransmission in the mammalian central nervous system. To test this hypothesis, we used in vivo microdialysis to measure changes in extracellular serotonin (5-hydroxytryptamine; 5-HT) in response to local infusion of μ-, δ-, and κ-opioid receptor ligands into the dorsal raphe nucleus (DRN), median raphe nucleus (MRN), and nucleus accumbens (NAcc) of freely behaving rats. The μ-opioids [d-Ala2-N-Me-Phe4,Gly5-ol]enkephalin (DAMGO), endomorphin-1, and endomorphin-2 were administered by reverse dialysis infusion into the DRN. In response, extracellular 5-HT was increased in the DRN, an effect that was blocked by the selective μ-receptor antagonist β-funaltrexamine, but not by the δ-receptor antagonistN,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH (ICI-174,864). Infusion of δ-receptor agonists, [d-Ala2,d-Len5]enkephalin (DADLE), [d-Pen2,5]enkephalin (DPDPE), and deltophin-II into the DRN also increased extracellular 5-HT, an effect that was blocked by selective δ-receptor antagonists. In contrast to the DRN, local infusion of μ- and δ-opioids had no effect on 5-HT in the MRN or NAcc. These data indicate that μ- and δ-opioid ligands have a selective influence on serotonergic neurons in the DRN. Finally, the κ-receptor agonist U-50,488 [trans-(±)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide] produced similar decreases in 5-HT during local infusion into the DRN, MRN, and NAcc. These results provide evidence of differential regulation of 5-HT release by opioid receptor subtypes in the midbrain raphe and forebrain.

Footnotes

  • ↵1 Present Address: Research, 151-C, Harvard Medical School VA Medical Center, 940 Belmont Street, Brockton, MA 02301-559

  • This research was supported by U.S. Public Health Service Grants MH51080 (S.B.A.) and DA14541 (R.T.).

  • DOI: 10.1124/jpet.102.037861

  • Abbreviations:
    5-HT
    5-hydroxytryptamine (serotonin)
    DRN
    dorsal raphe nucleus
    PAG
    periaqueductal gray
    ORL-1
    opioid receptor-like receptor 1
    CNS
    central nervous system
    MRN
    median raphe nucleus
    NAcc
    nucleus accumbens
    AP
    anteroposterior
    DV
    dorsoventricular
    ML
    mediolateral
    aCSF
    artificial cerebrospinal fluid
    DAMGO
    [d-Ala2-N-Me-Phe4,Gly5-ol]enkephalin
    DPDPE
    [d-Pen2,5]enkephalin
    U-50,488
    trans-(±)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide
    nor-BNI
    nor-binaltorphimine
    DADLE
    [d-Ala2,d-Len5]enkephalin
    β-FNA
    β-funaltrexamine
    ICI-174,864
    N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH
    • Received April 23, 2002.
    • Accepted July 15, 2002.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 303 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 303, Issue 2
1 Nov 2002
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System

Rui Tao and Sidney B. Auerbach
Journal of Pharmacology and Experimental Therapeutics November 1, 2002, 303 (2) 549-556; DOI: https://doi.org/10.1124/jpet.102.037861

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System

Rui Tao and Sidney B. Auerbach
Journal of Pharmacology and Experimental Therapeutics November 1, 2002, 303 (2) 549-556; DOI: https://doi.org/10.1124/jpet.102.037861
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
  • Rescue Pharmacology on Disease-Related GRIN Variants
  • Obesity thwarts preconditioning in TBI
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics